Published in Eur J Nucl Med Mol Imaging on May 14, 2003
Magnetoencephalographic imaging of resting-state functional connectivity predicts postsurgical neurological outcome in brain gliomas. Neurosurgery (2012) 1.61
Resting functional connectivity in patients with brain tumors in eloquent areas. Ann Neurol (2011) 1.29
Exploring the neurosurgical anatomy of the human insula: a combined and comparative anatomic-radiologic study. Surg Radiol Anat (2010) 0.83
Decoupling function and anatomy in atlases of functional connectivity patterns: language mapping in tumor patients. Neuroimage (2014) 0.82
Awake surgery in low-grade gliomas harboring eloquent areas: 3-year mean follow-up. Neurol Sci (2011) 0.79
Infiltration of the basal ganglia by brain tumors is associated with the development of co-dominant language function on fMRI. Brain Lang (2016) 0.77
Clinical applications of imaging biomarkers. Part 2. The neurosurgeon's perspective. Br J Radiol (2011) 0.76
Cortical and Subcortical Structural Plasticity Associated with the Glioma Volumes in Patients with Cerebral Gliomas Revealed by Surface-Based Morphometry. Front Neurol (2017) 0.75
A three-dimensional statistical analysis for CBF activation studies in human brain. J Cereb Blood Flow Metab (1992) 11.25
Role of left inferior prefrontal cortex in retrieval of semantic knowledge: a reevaluation. Proc Natl Acad Sci U S A (1997) 7.19
Positron emission tomographic studies of the cortical anatomy of single-word processing. Nature (1988) 6.90
Identification of a pathway for intelligible speech in the left temporal lobe. Brain (2000) 5.54
Voice-selective areas in human auditory cortex. Nature (2000) 5.18
Functional specialization for semantic and phonological processing in the left inferior prefrontal cortex. Neuroimage (1999) 4.93
Brain activation modulated by sentence comprehension. Science (1996) 4.19
Cortical language localization in left, dominant hemisphere. An electrical stimulation mapping investigation in 117 patients. J Neurosurg (1989) 4.18
Functional anatomy of a common semantic system for words and pictures. Nature (1996) 4.14
Brain regions involved in articulation. Lancet (1999) 2.97
Discrete cortical regions associated with knowledge of color and knowledge of action. Science (1995) 2.86
Differential capacity of left and right hemispheric areas for compensation of poststroke aphasia. Ann Neurol (1999) 2.57
Enhanced detection of focal brain responses using intersubject averaging and change-distribution analysis of subtracted PET images. J Cereb Blood Flow Metab (1988) 2.38
Mechanisms of recovery from aphasia: evidence from positron emission tomography studies. J Neurol Neurosurg Psychiatry (1999) 2.18
Neural correlates of recovery from aphasia after damage to left inferior frontal cortex. Neurology (2000) 2.08
Recovery from Wernicke's aphasia: a positron emission tomographic study. Ann Neurol (1995) 1.86
Plasticity of language-related brain function during recovery from stroke. Stroke (1999) 1.77
Training-induced brain plasticity in aphasia. Brain (1999) 1.73
Recovery from nonfluent aphasia after melodic intonation therapy: a PET study. Neurology (1996) 1.73
Intersubject variability in cortical activations during a complex language task. Neuroimage (2000) 1.36
Brain plasticity in poststroke aphasia: what is the contribution of the right hemisphere? Brain Lang (1998) 1.24
Neural correlates of semantic and episodic memory retrieval. Neuropsychologia (1999) 1.19
Plasticity of language networks in patients with brain tumors: a positron emission tomography activation study. Ann Neurol (2001) 1.17
Cerebral areas associated with motor control of speech in humans. J Appl Physiol (1985) (1997) 1.14
A common language network for comprehension and production: a contribution to the definition of language epicenters with PET. Neuroimage (2000) 1.13
An interactive technique for three-dimensional image registration: validation for PET, SPECT, MRI and CT brain studies. J Nucl Med (1994) 1.08
A direct comparison of PET activation and electrocortical stimulation mapping for language localization. Neurology (1997) 1.01
Speech-induced cerebral metabolic activation reflects recovery from aphasia. J Neurol Sci (1997) 1.00
Preoperative activation and intraoperative stimulation of language-related areas in patients with glioma. Neurosurgery (1997) 0.99
Role of the nondominant hemisphere and undamaged area during word repetition in poststroke aphasics. A PET activation study. Stroke (1996) 0.98
Language organization in patients with early and late left-hemisphere lesion: a PET study. Neuropsychologia (1999) 0.92
Comparative localization of auditory comprehension by using functional magnetic resonance imaging and cortical stimulation. J Neurosurg (1999) 0.89
Reliability of PET activation across statistical methods, subject groups, and sample sizes. Hum Brain Mapp (1996) 0.87
Positron emission tomography [15O]water studies with short interscan interval for single-subject and group analysis: influence of background subtraction. J Cereb Blood Flow Metab (1998) 0.83
Functional brain mapping using positron emission tomography scanning in preoperative neurosurgical planning for pediatric brain tumors. J Neurosurg (1999) 0.80
Preoperative motor system brain mapping using positron emission tomography and statistical parametric mapping: hints on cortical reorganisation. J Neurol Neurosurg Psychiatry (2003) 0.80
Use of positron emission tomography for presurgical localization of eloquent brain areas in children with seizures. Pediatr Neurosurg (1997) 0.78
Functional PET scanning in the preoperative assessment of cerebral arteriovenous malformations. Stereotact Funct Neurosurg (1995) 0.77
Language localization with activation positron emission tomography scanning. Neurosurgery (1992) 0.77
Within-study repeated measurements to increase sensitivity for positron emission tomography activation studies. J Cereb Blood Flow Metab (1998) 0.76
Three-dimensional imaging of cortical structure, function and glioma for tumor resection. J Nucl Med (1997) 0.76
Transplantation of blood-derived progenitor cells after recanalization of chronic coronary artery occlusion: first randomized and placebo-controlled study. Circ Res (2005) 3.20
Percutaneous coronary angioplasty compared with exercise training in patients with stable coronary artery disease: a randomized trial. Circulation (2004) 3.02
Correlation between dopamine D(2) receptors in the ventral striatum and central processing of alcohol cues and craving. Am J Psychiatry (2004) 2.84
Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study. Lancet Neurol (2011) 2.84
qPET - a quantitative extension of the Deauville scale to assess response in interim FDG-PET scans in lymphoma. Eur J Nucl Med Mol Imaging (2014) 2.51
New reference intervals for thyrotropin and thyroid hormones based on National Academy of Clinical Biochemistry criteria and regular ultrasonography of the thyroid. Clin Chem (2005) 2.24
Modified open-door laminoplasty for the surgical treatment of cervical spondylotic myelopathy in elderly patients. Acta Neurochir (Wien) (2014) 1.96
Transvenous treatment of carotid cavernous and dural arteriovenous fistulae: results for 31 patients and review of the literature. Neurosurgery (2003) 1.76
Diverse functional properties of Wilson disease ATP7B variants. Gastroenterology (2012) 1.61
Association of low striatal dopamine d2 receptor availability with nicotine dependence similar to that seen with other drugs of abuse. Am J Psychiatry (2008) 1.53
Correlation between automated writing movements and striatal dopaminergic innervation in patients with Wilson's disease. J Neurol (2002) 1.43
Correlation of alcohol craving with striatal dopamine synthesis capacity and D2/3 receptor availability: a combined [18F]DOPA and [18F]DMFP PET study in detoxified alcoholic patients. Am J Psychiatry (2005) 1.41
Serial 18F-fluoro-2-deoxy-D-glucose positron emission tomography and magnetic resonance imaging of paraneoplastic limbic encephalitis. Arch Neurol (2004) 1.40
[18F]Fluoroazomycinarabinofuranoside (18FAZA) and [18F]Fluoromisonidazole (18FMISO): a comparative study of their selective uptake in hypoxic cells and PET imaging in experimental rat tumors. Nucl Med Biol (2003) 1.36
SNM practice guideline for dopamine transporter imaging with 123I-ioflupane SPECT 1.0. J Nucl Med (2011) 1.28
Combined evaluation of FDG-PET and MRI improves detection and differentiation of dementia. PLoS One (2011) 1.24
Differential effects of global and cerebellar normalization on detection and differentiation of dementia in FDG-PET studies. Neuroimage (2009) 1.23
High opiate receptor binding potential in the human lateral pain system. Neuroimage (2005) 1.20
European multicentre database of healthy controls for [123I]FP-CIT SPECT (ENC-DAT): age-related effects, gender differences and evaluation of different methods of analysis. Eur J Nucl Med Mol Imaging (2012) 1.19
SPM-based count normalization provides excellent discrimination of mild Alzheimer's disease and amnestic mild cognitive impairment from healthy aging. Neuroimage (2008) 1.16
Parametric mapping of binding in human brain of D2 receptor ligands of different affinities. J Nucl Med (2005) 1.15
Carotid cavernous fistula: embolization via a bilateral superior ophthalmic vein approach. AJNR Am J Neuroradiol (2002) 1.12
Validation of an evaluation routine for left ventricular volumes, ejection fraction and wall motion from gated cardiac FDG PET: a comparison with cardiac magnetic resonance imaging. Eur J Nucl Med Mol Imaging (2003) 1.11
Summary report of the First International Workshop on PET/MR imaging, March 19-23, 2012, Tübingen, Germany. Mol Imaging Biol (2013) 1.10
Navigated transoral approach to the cranial base and the craniocervical junction: technical note. Neurosurgery (2003) 1.10
Net influx of plasma 6-[18F]fluoro-L-DOPA (FDOPA) to the ventral striatum correlates with prefrontal processing of affective stimuli. Eur J Neurosci (2006) 1.10
Executive deficits are related to the inferior frontal junction in early dementia. Brain (2011) 1.09
Definition of primary and secondary glioblastoma--letter. Clin Cancer Res (2014) 1.09
Reduced alpha4beta2*-nicotinic acetylcholine receptor binding and its relationship to mild cognitive and depressive symptoms in Parkinson disease. Arch Gen Psychiatry (2009) 1.08
PET quantification of 18F-florbetaben binding to β-amyloid deposits in human brains. J Nucl Med (2013) 1.08
Individualized quantification of brain β-amyloid burden: results of a proof of mechanism phase 0 florbetaben PET trial in patients with Alzheimer's disease and healthy controls. Eur J Nucl Med Mol Imaging (2011) 1.06
Choice of reference area in studies of Alzheimer's disease using positron emission tomography with fluorodeoxyglucose-F18. Psychiatry Res (2008) 1.06
Decreased cerebral α4β2* nicotinic acetylcholine receptor availability in patients with mild cognitive impairment and Alzheimer's disease assessed with positron emission tomography. Eur J Nucl Med Mol Imaging (2010) 1.05
Cardiac resynchronization therapy homogenizes myocardial glucose metabolism and perfusion in dilated cardiomyopathy and left bundle branch block. J Am Coll Cardiol (2003) 1.04
Meta-analysis based SVM classification enables accurate detection of Alzheimer's disease across different clinical centers using FDG-PET and MRI. Psychiatry Res (2012) 1.04
Comparison of three-dimensional rotational angiography with digital subtraction angiography in the assessment of ruptured cerebral aneurysms. AJNR Am J Neuroradiol (2002) 1.03
Head and neck paragangliomas: Report of 175 patients (1989-2010). Head Neck (2011) 1.03
Quantification of left ventricular volumes and ejection fraction from gated 99mTc-MIBI SPECT: MRI validation and comparison of the Emory Cardiac Tool Box with QGS and 4D-MSPECT. J Nucl Med (2005) 1.02
PET/MR in children. Initial clinical experience in paediatric oncology using an integrated PET/MR scanner. Pediatr Radiol (2013) 0.99
Value of semiquantitative analysis for clinical reporting of 123I-2-β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl)nortropane SPECT studies. J Nucl Med (2013) 0.98
Reduced cerebral fluoro-L-dopamine uptake in adult patients suffering from phenylketonuria. J Cereb Blood Flow Metab (2007) 0.97
Diagnosis and treatment of pancreatic metastases of a papillary thyroid carcinoma. Thyroid (2010) 0.97
18F-fluorodeoxyglucose hypometabolism in cerebellar tonsil and flocculus in downbeat nystagmus. Neuroreport (2006) 0.97
Executive and behavioral deficits share common neural substrates in frontotemporal lobar degeneration - a pilot FDG-PET study. Psychiatry Res (2010) 0.96
Cholinergic receptor subtypes and their role in cognition, emotion, and vigilance control: an overview of preclinical and clinical findings. Psychopharmacology (Berl) (2011) 0.96
Positron emission tomography for staging esophageal cancer: does it lead to a different therapeutic approach? World J Surg (2003) 0.96
Validation of 4D-MSPECT and QGS for quantification of left ventricular volumes and ejection fraction from gated 99mTc-MIBI SPET: comparison with cardiac magnetic resonance imaging. Eur J Nucl Med Mol Imaging (2004) 0.94
Automatic semi-quantification of [123I]FP-CIT SPECT scans in healthy volunteers using BasGan version 2: results from the ENC-DAT database. Eur J Nucl Med Mol Imaging (2012) 0.93
Serotonin and dopamine transporter imaging in patients with obsessive-compulsive disorder. Psychiatry Res (2005) 0.93
The striatal and extrastriatal D2/D3 receptor-binding profile of clozapine in patients with schizophrenia. Neuropsychopharmacology (2006) 0.93
Reference cluster normalization improves detection of frontotemporal lobar degeneration by means of FDG-PET. PLoS One (2013) 0.93
FDG PET and tumour markers in the diagnosis of recurrent and metastatic breast cancer. Eur J Nucl Med Mol Imaging (2004) 0.93
Different mechanisms for changes in glucose uptake of the right and left ventricular myocardium in pulmonary hypertension. J Nucl Med (2005) 0.92
[18F]Fluorodeoxyglucose positron emission tomography for detection of bone marrow involvement in children and adolescents with Hodgkin's lymphoma. J Clin Oncol (2011) 0.92
Florbetaben to trace amyloid-β in the Alzheimer brain by means of PET. J Alzheimers Dis (2011) 0.91
Prospective evaluation of positron emission tomography in the preoperative staging of esophageal carcinoma. Arch Surg (2004) 0.90
Metabolic and structural connectivity within the default mode network relates to working memory performance in young healthy adults. Neuroimage (2013) 0.90
Residual lymph node metastasis in stage 4 neuroblastoma--advantage of radio-guided surgery? Pediatr Hematol Oncol (2010) 0.90
Measurement of the alpha4beta2* nicotinic acetylcholine receptor ligand 2-[(18)F]Fluoro-A-85380 and its metabolites in human blood during PET investigation: a methodological study. Nucl Med Biol (2007) 0.90
Concordant pre- and postsynaptic deficits of dopaminergic neurotransmission in neurologic Wilson disease. AJNR Am J Neuroradiol (2003) 0.89
Effects of subthalamic nucleus stimulation on striatal dopaminergic transmission in patients with Parkinson's disease within one-year follow-up. J Neurol (2008) 0.89
Assessment of α7 nicotinic acetylcholine receptor availability in juvenile pig brain with [¹⁸F]NS10743. Eur J Nucl Med Mol Imaging (2011) 0.89
No association between striatal dopamine transporter binding and body mass index: a multi-center European study in healthy volunteers. Neuroimage (2012) 0.89
Quantification of left ventricular volumes and ejection fraction from gated 99mTc-MIBI SPECT: validation of an elastic surface model approach in comparison to cardiac magnetic resonance imaging, 4D-MSPECT and QGS. Eur J Nucl Med Mol Imaging (2007) 0.88
The value of positron emission tomography in the follow-up for breast cancer. Anticancer Res (2003) 0.88
Combined PET/MR: Where are we now? Summary report of the second international workshop on PET/MR imaging April 8-12, 2013, Tubingen, Germany. Mol Imaging Biol (2014) 0.88
Positron-emission tomography imaging in the diagnosis of bisphosphonate-related osteonecrosis of the jaw. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2009) 0.87
Changes in myocardial perfusion due to physical exercise in patients with stable coronary artery disease. Eur J Nucl Med Mol Imaging (2005) 0.87
Dopamine transporter imaging in adult patients with attention-deficit/hyperactivity disorder. Psychiatry Res (2009) 0.87
In vivo measurement of nicotinic acetylcholine receptors with [18F]norchloro-fluoro-homoepibatidine. Synapse (2008) 0.87
Dissociating behavioral disorders in early dementia-An FDG-PET study. Psychiatry Res (2011) 0.87
Dissociating memory networks in early Alzheimer's disease and frontotemporal lobar degeneration - a combined study of hypometabolism and atrophy. PLoS One (2013) 0.87
Human dopamine receptor D2/D3 availability predicts amygdala reactivity to unpleasant stimuli. Hum Brain Mapp (2010) 0.87
Randomized comparison of selective internal radiotherapy (SIRT) versus drug-eluting bead transarterial chemoembolization (DEB-TACE) for the treatment of hepatocellular carcinoma. Cardiovasc Intervent Radiol (2014) 0.86
Neural correlates of the DemTect in Alzheimer's disease and frontotemporal lobar degeneration - A combined MRI & FDG-PET study. Neuroimage Clin (2013) 0.86
Developmental and amyloid plaque-related changes in cerebral cortical capillaries in transgenic Tg2576 Alzheimer mice. Int J Dev Neurosci (2006) 0.86
Basal opioid receptor binding is associated with differences in sensory perception in healthy human subjects: a [18F]diprenorphine PET study. Neuroimage (2009) 0.86
Malignant germ cell tumors metastatic to the brain: a model for a curable neoplasm? The Freiburg experience and a review of the literature. J Neurooncol (2002) 0.86
Labelling of commercially available human serum albumin kits with 68Ga as surrogates for 99mTc-MAA microspheres. Appl Radiat Isot (2010) 0.86
Investigating dopaminergic neurotransmission with 123I-FP-CIT SPECT: comparability of modern SPECT systems. J Nucl Med (2003) 0.85
Integrated PET/MRI for planning navigated biopsies in pediatric brain tumors. Childs Nerv Syst (2014) 0.85
Reaction time facilitation for horizontally moving auditory-visual stimuli. J Vis (2010) 0.85
Reduced serotonin transporter-availability in obsessive-compulsive disorder (OCD). Eur Arch Psychiatry Clin Neurosci (2004) 0.85
Decreased dopamine D2/D3-receptor binding in temporal lobe epilepsy: an [18F]fallypride PET study. Epilepsia (2006) 0.85
[18F]3'-deoxy-3'-fluorothymidine-PET in NHL patients: whole-body biodistribution and imaging of lymphoma manifestations--a pilot study. Cancer Biother Radiopharm (2004) 0.85
In vivo imaging of dopamine receptors in a model of temporal lobe epilepsy. Epilepsia (2009) 0.85
Alterations in cholinergic and non-cholinergic neurotransmitter receptor densities in transgenic Tg2576 mouse brain with beta-amyloid plaque pathology. Int J Dev Neurosci (2003) 0.85
Radiosynthesis of racemic and enantiomerically pure (-)-[18F]flubatine--a promising PET radiotracer for neuroimaging of α4β2 nicotinic acetylcholine receptors. Appl Radiat Isot (2013) 0.84
Surgical management of cervical spondylotic myelopathy - indications for anterior, posterior or combined procedures for decompression and stabilisation. Acta Neurochir (Wien) (2013) 0.84
Validation of QGS and 4D-MSPECT for quantification of left ventricular volumes and ejection fraction from gated 18F-FDG PET: comparison with cardiac MRI. J Nucl Med (2004) 0.84
Influence of scan duration on the accuracy of β-amyloid PET with florbetaben in patients with Alzheimer's disease and healthy volunteers. Eur J Nucl Med Mol Imaging (2012) 0.84
Imaging of the brain serotonin transporters (SERT) with 18F-labelled fluoromethyl-McN5652 and PET in humans. Eur J Nucl Med Mol Imaging (2012) 0.83
Is correction for age necessary in neuroimaging studies of the central serotonin transporter? Eur J Nucl Med Mol Imaging (2003) 0.83
Synthesis of novel 4- and 5-substituted benzyl ether derivatives of vesamicol and in vitro evaluation of their binding properties to the vesicular acetylcholine transporter site. Bioorg Med Chem (2004) 0.83
Relative quantification of indium-111 pentetreotide and gallium-68 DOTATOC uptake in the thyroid gland and association with thyroid pathologies. Thyroid (2009) 0.83